Genomic deletions upstream of lamin B1 lead to atypical autosomal dominant leukodystrophy

Abstract

<h3>Objective</h3> Clinical, radiologic, and molecular analysis of patients with genomic deletions upstream of the <i>LMNB1</i> gene. <h3>Methods</h3> Detailed neurologic, MRI examinations, custom array comparative genomic hybridization (aCGH) analysis, and expression analysis were performed in patients at different clinical centers. All procedures were approved by institutional review boards of the respective institutions. <h3>Results</h3> Five patients from 3 independent families presented at ages ranging from 32 to 52 years with neurologic symptoms that included progressive hypophonia, upper and lower limb weakness and spasticity, and cerebellar dysfunction and MRIs characterized by widespread white matter alterations. Patients had unique nonrecurrent deletions upstream of the <i>LMNB1</i>, varying in size from 250 kb to 670 kb. Deletion junctions were embedded in repetitive elements. Expression analysis revealed increased <i>LMNB1</i> expression in patient cells. <h3>Conclusions</h3> Our findings confirmed the association between <i>LMNB1</i> upstream deletions and leukodystrophy previously reported in a single family, expanding the phenotypic and molecular description of this condition. Although clinical and radiologic features overlapped with those of autosomal dominant leukodystrophy because of <i>LMNB1</i> duplications, patients with deletions upstream of <i>LMNB1</i> had an earlier age at symptom onset, lacked early dysautonomia, and appeared to have lesser involvement of the cerebellum and sparing of the spinal cord diameter on MRI. aCGH analysis defined a smaller minimal critical region required for disease causation and revealed that deletions occur at repetitive DNA genomic elements. Search for <i>LMNB1</i> structural variants (duplications and upstream deletions) should be an integral part of the investigation of patients with autosomal dominant adult-onset leukodystrophy.